Drugs that target the endocannabinoid system are of interest as pharmacological options to
combat cancer and to improve the life quality of cancer patients. From this perspective …

Background Approximately 18% of patients with cancer use cannabis at one time as
palliation or treatment for their cancer. We performed a systematic review of randomized …

As medical cannabis becomes legal in more states, cancer patients are increasingly
interested in the potential utility of the ancient botanical in their treatment regimen. Although …

Medical cannabis use is increasing worldwide. Clinicians are commonly asked by patients
to provide guidance on its safety and efficacy. Although there has been an increase in …

Background The goal of this study was to characterize cannabis use among patients with
breast cancer, including their reasons for and timing of use, their sources of cannabis …

Abstract Combination tetrahydrocannabinol (THC)/cannabidiol (CBD) medicines or CBD-
only medicines are prospective treatments for chronic pain, stress, anxiety, depression, and …

Purpose The prevalence of medical cannabis (MC) use in patients with cancer is growing,
but questions about safety, efficacy, and dosing remain. Conducting randomized, controlled …

Cannabis use and interest continues to increase among patients with cancer and
caregivers. High-quality research remains scant in many areas, causing hesitancy or …

The side effects of cancer therapy continue to cause significant health and cost burden to the
patient, their friends and family, and governments. A major barrier in the way in which these …

The use of medical cannabis (MC) to treat cancer-related symptoms is rising. However, there
is a lack of long-term trials to assess the benefits and safety of MC treatment in this …